JAMA-Journal of the American Medical Association Phil B. Fontanarosa, MD, MBA1; Howard Bauchner, MD1 Author Affiliations Article Information JAMA. Published online April 17, 2020. doi:10.1001/jama.2020.6582 Related Articles 6 months ago, the novel coronavirus now known as severe acute respiratory syndrome coronavirus … [Read more...] about COVID-19—Looking Beyond Tomorrow for Health Care and Society
Archives for April 2020
COVID-19 CLINICAL STUDY FROM CHINA PUBLISHED FEBRUARY 2020 IN LANCET MEDICAL JOURNAL
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study By:Chen, NS (Chen, Nanshan)[ 1 ] ; Zhou, M (Zhou, Min)[ 5,6 ] ; Dong, X (Dong, Xuan)[ 1 ] ; Qu, JM (Qu, Jieming)[ 5,6 ] ; Gong, FY (Gong, Fengyun)[ 2 ] ; Han, Y (Han, … [Read more...] about COVID-19 CLINICAL STUDY FROM CHINA PUBLISHED FEBRUARY 2020 IN LANCET MEDICAL JOURNAL
CHINESE MEDICAL STUDY ON COVID-19 THAT WAS REMOVED BY CHINESE GOVERNMENT ON MARCH 25, 2020
Study Title: Clinical Characteristics of Coronavirus Disease 2019 in China (references included) Fudan University Link: https://web.archive.org/web/20200409053204/http://www.it.fudan.edu.cn/Data/View/3657 CONCLUSIONS: During the first 2 months of the current outbreak, Covid-19 spread rapidly throughout China and caused varying degrees of illness. Patients … [Read more...] about CHINESE MEDICAL STUDY ON COVID-19 THAT WAS REMOVED BY CHINESE GOVERNMENT ON MARCH 25, 2020
Florida: How Courts and Litigants Have Adapted to the New Normal Amid the Coronavirus Pandemic and a Forecast for the Future
Written by Karina D. Rodrigues Kelley | Uustal www.kelleyuustal.com Several factors make Florida especially vulnerable to COVID-19. Florida is the third largest state in the country in population. About 1 in 5 Floridians is over 65 years old. Disney World attracts tourists from all over the world year-round. Spring breakers crowded Florida beaches in March as the … [Read more...] about Florida: How Courts and Litigants Have Adapted to the New Normal Amid the Coronavirus Pandemic and a Forecast for the Future
FDA Issues Recall Statement On All Zantac (Ranitidine) Products
FDA NEWS RELEASE FDA Requests Removal of All Ranitidine Products (Zantac) from the Market FDA Advises Consumers, Patients and Health Care Professionals After New FDA Studies Show Risk The U.S. Food and Drug Administration today announced it is requesting manufacturers withdraw all prescription and over-the-counter (OTC) ranitidine drugs from the … [Read more...] about FDA Issues Recall Statement On All Zantac (Ranitidine) Products